Human Microbiome Therapeutics Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Microbiome Therapeutics
1.2 Key Market Segments
1.2.1 Human Microbiome Therapeutics Segment by Type
1.2.2 Human Microbiome Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Human Microbiome Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Human Microbiome Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Microbiome Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Human Microbiome Therapeutics Market Competitive Landscape
3.1 Global Human Microbiome Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Human Microbiome Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Microbiome Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Microbiome Therapeutics Sales Sites, Area Served, Product Type
3.6 Human Microbiome Therapeutics Market Competitive Situation and Trends
3.6.1 Human Microbiome Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Microbiome Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Human Microbiome Therapeutics Industry Chain Analysis
4.1 Human Microbiome Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Microbiome Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Human Microbiome Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Microbiome Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Human Microbiome Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Human Microbiome Therapeutics Price by Type (2019-2024)
7 Human Microbiome Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Microbiome Therapeutics Market Sales by Application (2019-2024)
7.3 Global Human Microbiome Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Human Microbiome Therapeutics Sales Growth Rate by Application (2019-2024)
8 Human Microbiome Therapeutics Market Segmentation by Region
8.1 Global Human Microbiome Therapeutics Sales by Region
8.1.1 Global Human Microbiome Therapeutics Sales by Region
8.1.2 Global Human Microbiome Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Human Microbiome Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Microbiome Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Microbiome Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Microbiome Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Microbiome Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Enterome Bioscience
9.1.1 Enterome Bioscience Human Microbiome Therapeutics Basic Information
9.1.2 Enterome Bioscience Human Microbiome Therapeutics Product Overview
9.1.3 Enterome Bioscience Human Microbiome Therapeutics Product Market Performance
9.1.4 Enterome Bioscience Business Overview
9.1.5 Enterome Bioscience Human Microbiome Therapeutics SWOT Analysis
9.1.6 Enterome Bioscience Recent Developments
9.2 Rebiotix
9.2.1 Rebiotix Human Microbiome Therapeutics Basic Information
9.2.2 Rebiotix Human Microbiome Therapeutics Product Overview
9.2.3 Rebiotix Human Microbiome Therapeutics Product Market Performance
9.2.4 Rebiotix Business Overview
9.2.5 Rebiotix Human Microbiome Therapeutics SWOT Analysis
9.2.6 Rebiotix Recent Developments
9.3 Seres Therapeutics
9.3.1 Seres Therapeutics Human Microbiome Therapeutics Basic Information
9.3.2 Seres Therapeutics Human Microbiome Therapeutics Product Overview
9.3.3 Seres Therapeutics Human Microbiome Therapeutics Product Market Performance
9.3.4 Seres Therapeutics Human Microbiome Therapeutics SWOT Analysis
9.3.5 Seres Therapeutics Business Overview
9.3.6 Seres Therapeutics Recent Developments
9.4 Vedanta Biosciences
9.4.1 Vedanta Biosciences Human Microbiome Therapeutics Basic Information
9.4.2 Vedanta Biosciences Human Microbiome Therapeutics Product Overview
9.4.3 Vedanta Biosciences Human Microbiome Therapeutics Product Market Performance
9.4.4 Vedanta Biosciences Business Overview
9.4.5 Vedanta Biosciences Recent Developments
9.5 Bristol-Myers Squibb
9.5.1 Bristol-Myers Squibb Human Microbiome Therapeutics Basic Information
9.5.2 Bristol-Myers Squibb Human Microbiome Therapeutics Product Overview
9.5.3 Bristol-Myers Squibb Human Microbiome Therapeutics Product Market Performance
9.5.4 Bristol-Myers Squibb Business Overview
9.5.5 Bristol-Myers Squibb Recent Developments
9.6 Johnson and Johnson
9.6.1 Johnson and Johnson Human Microbiome Therapeutics Basic Information
9.6.2 Johnson and Johnson Human Microbiome Therapeutics Product Overview
9.6.3 Johnson and Johnson Human Microbiome Therapeutics Product Market Performance
9.6.4 Johnson and Johnson Business Overview
9.6.5 Johnson and Johnson Recent Developments
9.7 Takeda Pharmaceutical
9.7.1 Takeda Pharmaceutical Human Microbiome Therapeutics Basic Information
9.7.2 Takeda Pharmaceutical Human Microbiome Therapeutics Product Overview
9.7.3 Takeda Pharmaceutical Human Microbiome Therapeutics Product Market Performance
9.7.4 Takeda Pharmaceutical Business Overview
9.7.5 Takeda Pharmaceutical Recent Developments
10 Human Microbiome Therapeutics Market Forecast by Region
10.1 Global Human Microbiome Therapeutics Market Size Forecast
10.2 Global Human Microbiome Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Microbiome Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Human Microbiome Therapeutics Market Size Forecast by Region
10.2.4 South America Human Microbiome Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Microbiome Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Human Microbiome Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Microbiome Therapeutics by Type (2025-2030)
11.1.2 Global Human Microbiome Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Microbiome Therapeutics by Type (2025-2030)
11.2 Global Human Microbiome Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Human Microbiome Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Human Microbiome Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Microbiome Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Human Microbiome Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Human Microbiome Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Microbiome Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Microbiome Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Therapeutics as of 2022)
Table 10. Global Market Human Microbiome Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Microbiome Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Human Microbiome Therapeutics Product Type
Table 13. Global Human Microbiome Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Microbiome Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Microbiome Therapeutics Market Challenges
Table 22. Global Human Microbiome Therapeutics Sales by Type (K Units)
Table 23. Global Human Microbiome Therapeutics Market Size by Type (M USD)
Table 24. Global Human Microbiome Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Human Microbiome Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Human Microbiome Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Microbiome Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Human Microbiome Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Human Microbiome Therapeutics Sales (K Units) by Application
Table 30. Global Human Microbiome Therapeutics Market Size by Application
Table 31. Global Human Microbiome Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Human Microbiome Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Human Microbiome Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Microbiome Therapeutics Market Share by Application (2019-2024)
Table 35. Global Human Microbiome Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Microbiome Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Human Microbiome Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Human Microbiome Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Human Microbiome Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Human Microbiome Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Human Microbiome Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Human Microbiome Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Enterome Bioscience Human Microbiome Therapeutics Basic Information
Table 44. Enterome Bioscience Human Microbiome Therapeutics Product Overview
Table 45. Enterome Bioscience Human Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Enterome Bioscience Business Overview
Table 47. Enterome Bioscience Human Microbiome Therapeutics SWOT Analysis
Table 48. Enterome Bioscience Recent Developments
Table 49. Rebiotix Human Microbiome Therapeutics Basic Information
Table 50. Rebiotix Human Microbiome Therapeutics Product Overview
Table 51. Rebiotix Human Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Rebiotix Business Overview
Table 53. Rebiotix Human Microbiome Therapeutics SWOT Analysis
Table 54. Rebiotix Recent Developments
Table 55. Seres Therapeutics Human Microbiome Therapeutics Basic Information
Table 56. Seres Therapeutics Human Microbiome Therapeutics Product Overview
Table 57. Seres Therapeutics Human Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Seres Therapeutics Human Microbiome Therapeutics SWOT Analysis
Table 59. Seres Therapeutics Business Overview
Table 60. Seres Therapeutics Recent Developments
Table 61. Vedanta Biosciences Human Microbiome Therapeutics Basic Information
Table 62. Vedanta Biosciences Human Microbiome Therapeutics Product Overview
Table 63. Vedanta Biosciences Human Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Vedanta Biosciences Business Overview
Table 65. Vedanta Biosciences Recent Developments
Table 66. Bristol-Myers Squibb Human Microbiome Therapeutics Basic Information
Table 67. Bristol-Myers Squibb Human Microbiome Therapeutics Product Overview
Table 68. Bristol-Myers Squibb Human Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Recent Developments
Table 71. Johnson and Johnson Human Microbiome Therapeutics Basic Information
Table 72. Johnson and Johnson Human Microbiome Therapeutics Product Overview
Table 73. Johnson and Johnson Human Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Johnson and Johnson Business Overview
Table 75. Johnson and Johnson Recent Developments
Table 76. Takeda Pharmaceutical Human Microbiome Therapeutics Basic Information
Table 77. Takeda Pharmaceutical Human Microbiome Therapeutics Product Overview
Table 78. Takeda Pharmaceutical Human Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Takeda Pharmaceutical Business Overview
Table 80. Takeda Pharmaceutical Recent Developments
Table 81. Global Human Microbiome Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 82. Global Human Microbiome Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 83. North America Human Microbiome Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 84. North America Human Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 85. Europe Human Microbiome Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 86. Europe Human Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 87. Asia Pacific Human Microbiome Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 88. Asia Pacific Human Microbiome Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 89. South America Human Microbiome Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 90. South America Human Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 91. Middle East and Africa Human Microbiome Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 92. Middle East and Africa Human Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 93. Global Human Microbiome Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 94. Global Human Microbiome Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 95. Global Human Microbiome Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 96. Global Human Microbiome Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 97. Global Human Microbiome Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Human Microbiome Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Microbiome Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Human Microbiome Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Human Microbiome Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Microbiome Therapeutics Market Size by Country (M USD)
Figure 11. Human Microbiome Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Human Microbiome Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Human Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Microbiome Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Microbiome Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Microbiome Therapeutics Market Share by Type
Figure 18. Sales Market Share of Human Microbiome Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Human Microbiome Therapeutics by Type in 2023
Figure 20. Market Size Share of Human Microbiome Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Human Microbiome Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Microbiome Therapeutics Market Share by Application
Figure 24. Global Human Microbiome Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Human Microbiome Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Human Microbiome Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Human Microbiome Therapeutics Market Share by Application in 2023
Figure 28. Global Human Microbiome Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Microbiome Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Human Microbiome Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Human Microbiome Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Human Microbiome Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Human Microbiome Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Human Microbiome Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Human Microbiome Therapeutics Sales Market Share by Region in 2023
Figure 44. China Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Human Microbiome Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Human Microbiome Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Human Microbiome Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Human Microbiome Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Human Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Human Microbiome Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Human Microbiome Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Human Microbiome Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Human Microbiome Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Human Microbiome Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Human Microbiome Therapeutics Market Share Forecast by Application (2025-2030)
Industry Market Size
